Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Penwest, Alvogen Sign Multi-Drug Generics Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Penwest, Alvogen Sign Multi-Drug Generics Pact

Penwest Pharmaceuticals and Alvogen, Inc. have signed a drug development and commercialization agreement under which the two companies will work to identify and select as many as five compounds for generic development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Penwest Pharmaceuticals and Alvogen, Inc. have signed a drug development and commercialization agreement under which the two companies will work to identify and select as many as five compounds for generic development. Penwest may use its TIMERx technology for each compound selected and will formulate the compounds and receive development milestones and royalty payments. Alvogen will be responsible for manufacturing, clinical trials and regulatory filings for each of the formulations, as well as commercialization of the products worldwide.

Jennifer L. Good, Penwest’s president and chief executive officer, said, “We are very pleased to be partnering with Alvogen because of their record for successful product introductions within the generic pharmaceutical industry. This multi-drug, multi-national agreement allows Penwest to leverage its drug delivery technology for the formulation of generic drugs, an important segment of the market for extended release technology.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics